¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"anterior myocardial infarction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • anterior atlantoaxial ligament
    ¾Õ°í¸®Áß¼èÀδë, ÀüȯÃàÀδë
  • anterior axillary line
    ¾Õ°Üµå¶û¼±, Àü¾×¿Í¼±
  • anterior basal segment
    ¾Õ¹Ù´Ú±¸¿ª
  • anterior basal segmental bronchus
    ¾Õ¹Ù´Ú±¸¿ª±â°üÁö
  • anterior cerebral artery
    ¾Õ´ë³úµ¿¸Æ, Àü´ë³úµ¿¸Æ
  • anterior chamber
    ¾Õ¹æ, Àü¹æ
  • anterior chamber angle
    ¾Õ¹æ°¢, Àü¹æ°¢
  • anterior cruciate ligament
    ¾Õ½ÊÀÚÀδë, Àü½ÊÀÚÀδë
  • anterior fontanelle
    ¾Õ¼ý±¸¸Û, ´ëõ¹®
  • anterior horn
    ¾Õ»Ô
  • anterior hyaloid fibrovascular proliferation
    ¾ÕÀ¯¸®Ã¼¼¶À¯Ç÷°üÁõ½Ä
  • anterior inferior cerebellar artery
    ¾Õ¾Æ·¡¼Ò³úµ¿¸Æ, ÀüÇϼҳúµ¿¸Æ
  • anterior interosseous nerve syndrome
    ¾Õ»À»çÀ̽ŰæÁõÈıº, Àü¹æ°ñ°£½Å°æÁõÈıº
  • anterior interventricular sulcus
    ¾Õ½É½Ç»çÀ̰í¶û, Àü½É½Ç°£±¸
  • anterior labial commissure
    ¾ÕÀ½¼ø¿¬°áºÎ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • myocardial stimulant
    ½É±ÙÀÚ±ØÁ¦, °­½ÉÁ¦
  • myocardial perfusion scintigraphy
    ½É±ÙÁÖ»ç¼ú, ½ÉÀå±ÙÀ°¼¶±¤Á¶¿µ¼ú
  • anterior
    ¾Õ-
  • anterior chamber
    ¾Õ¹æ, Àü¹æ
  • anterior fontanelle
    ¾Õ¼ý±¸¸Û
  • anterior horn
    ¾Õ»Ô
  • anterior scleritis
    ¾Õ°ø¸·¿°
  • anterior staphyloma
    ¾ÕÆ÷µµÁ¾
  • anterior chamber angle
    ¾Õ¹æ°¢
  • anterior inferior cerebellar artery
    ¾Õ¾Æ·¡¼Ò³úµ¿¸Æ
  • anterior nasal aperture
    ¾ÕÄ౸¸Û
  • anterior spinal arthrodesis
    ¾ÕôÃß°íÁ¤¼ú, Àü¹æÃ´Ãß°íÁ¤¼ú
  • anterior subtemporal approach
    ¾Õ°üÀÚ¹ØÁ¢±Ù¹ý, Àü¹æÃøµÎÇÏÁ¢±Ù¹ý
  • anterior basal segment
    ¾Õ¹Ù´Ú±¸¿ª
  • anterior basal segmental bronchus
    ¾Õ¹Ù´Ú±¸¿ª±â°üÁö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • anterior (tonsillar) pilla
    Àü±¸°³±Ã, ±¸°³¼³±Ã
  • anterior ampullar nerve
    ¾ÕÆØ´ë½Å°æ
  • anterior amygdaloid area
    ¾ÕÆíµµ±¸¿ª
  • anterior arch
    ¾Õ°í¸®
  • anterior articular surface
    ¾Õ°üÀý¸é
  • anterior articular surface for talus
    ¾Õ¸ñ¸»°üÀý¸é
  • anterior ascending branch
    ¿À¸§¾Õ°¡Áö
  • anterior atlanto-occipital ligament
    (¾Õ°í¸®µÚÅë¼öÀδë)
  • anterior atlanto-occipital membrane
    ¾ÕȯÃßÈĵθ·, ÀüȯÃßÈĵθ·(îñü» õÐý­Ô騝
  • anterior atlanto-occipital membrane
    ¾Õ°í¸®µÚÅë¼ö¸·
  • anterior auricular branches
    ¾Õ±Ó¹ÙÄû°¡Áö
  • anterior auricular ligament
    ÀüÀ̰³Àδë
  • anterior auricular ligament
    ¾Õ±Ó¹ÙÄûÀδë
  • anterior auricular lymph node
    ÀüÀ̰³¸²ÇÁÀý
  • anterior auricular muscle
    ÀüÀ̰³±Ù
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cerebral infarction
    ³ú°æ»ö(ÒàÌÛßá).
  • cerebral infarction
    ³ú°æ»ö(¡­ÌÛßá)
  • coronary infarction
    °ü(»ó)µ¿¸Æ°æ»öÁõ(¡­ÌÛßáñø).
  • infarction
    °æ»ö
  • infarction
    °æ»ö(Áõ)(ÌÛßáñø).
  • infarction
    °æ»öÁõ(ÌÛßáñø)
  • infarction pain
    °æ»öÅë(ÌÛßá÷Ô).
  • infarction,red
    Àû»ö(°æ»ö)(îåßä¡­)
  • infarction,white
    ¹é»ö(°æ»ö)(¹é»ö¡­)
  • interal infarction
    Ãøº®°æ»ö(ö°ÛúÌÛßá).
  • lacunar infarction
    ¿­°ø°æ»öÁõ.
  • liver infarction
    °£°æ»öÁõ(ÊÜÌÛßáñø).
  • lung infarction
    Æó°æ»öÁõ(øËÌãßáñø).
  • mesenteric infarction
    Àå°£¸·°æ»ö(íóÊàØ¯ÌÛßá).
  • mesenteric infarction
    Àå°£¸·°æ»ö(ÌÛßá)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Anterior rami
    ¾Õ°¡Áö
    [¿¾ ¿ë¾î] ÀüÁö
  • Anterior ramus
    ¾Õ°¡Áö
    [¿¾ ¿ë¾î] ÀüÁö
  • Anterior intercostal branches
    ¾Õ°¥ºñ»çÀ̰¡Áö
    [¿¾ ¿ë¾î] Àü´Á°£Áö
  • Anterior intercostal veins
    ¾Õ°¥ºñ»çÀÌÁ¤¸Æ
    [¿¾ ¿ë¾î] Àü´Á°£Á¤¸Æ
  • Anterior axillary line
    ¾Õ°Üµå¶û¼±
    [¿¾ ¿ë¾î] Àü¾×¿Í¼±
  • Anterior conjunctival arteries
    ¾Õ°á¸·µ¿¸Æ
    [¿¾ ¿ë¾î] Àü°á¸·µ¿¸Æ
  • Anterior tubercle
    ¾Õ°áÀý
    [¿¾ ¿ë¾î] °æÃßÀü°áÀý
  • Anterior tubercle
    ¾Õ°áÀý
    [¿¾ ¿ë¾î] Àü°áÀý
  • Anterior limiting membrane
    ¾Õ°æ°èÆÇ
    [¿¾ ¿ë¾î] Àü°æ°èÆÇ
  • Anterior arch
    ¾Õ°í¸®
    [¿¾ ¿ë¾î] Àü±Ã
  • Anterior atlanto-occipital membrane
    ¾Õ°í¸®µÚÅë¼ö¸·
    [¿¾ ¿ë¾î] ÀüȯÃßÈĵθ·
  • Anterior tympanic artery
    ¾Õ°í½Çµ¿¸Æ
    [¿¾ ¿ë¾î] Àü°í½Çµ¿¸Æ
  • Anterior proper fascicles
    ¾Õ°íÀ¯´Ù¹ß
    [¿¾ ¿ë¾î] Àü°íÀ¯¼Ó
  • Anterior temporal branches
    ¾Õ°üÀÚ¿±°¡Áö
    [¿¾ ¿ë¾î] ÀüÃøµÎÁö
  • Anterior temporal artery
    ¾Õ°üÀÚ¿±µ¿¸Æ
    [¿¾ ¿ë¾î] ÀüÃøµÎµ¿¸Æ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • anterior lobe
    Àü¿±
  • anterior longitudinal ligament
    ÀüÁ¾Àδë
  • anterior mediastinum
    Á¾°ÝÀüºÎ
  • anterior meningeal artery
    Àü°æ¸·µ¿¸Æ
  • anterior nuclei of thalamus
    ½Ã»óÀüÇÙ
  • anterior palatine arch
    Àü±¸°³±Ã
  • anterior perforated substance
    ÀüÀ¯°ø¹°Áú
  • anterior pillar
    ±¸°³¼³±Ã, Àü±¸°³±Ã
  • anterior posterior view
    ÀüÈÄ»ó
  • anterior scalene muscle
    Àü»ç°¢±Ù
  • anterior segment
    Àü»ó¿±±¸
  • anterior spinal artery
    Àüô¼öµ¿¸Æ
  • anterior tibial artery
    Àü°æ°ñµ¿¸Æ
  • anterior tubercle
    Àü°áÀý
  • commissura anterior
    ¾Õ±³Â÷¿¬°á, Àü±³·Ã
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PI first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;...
AMI Acute Myocardial Infarction
  - Complications(Cx)
    1. Early ...
MI   1) Mitral Insufficient
    = MR
  2) Myocardial Infa...
DELIRIUM drugs-electrolytes-low temperature and lunacy-intoxication and intracranial processes-retention of u...
DMI Defense Mechanism Inventory; Diagnostic Medical Instruments; diaphragmatic myocardial infarction; di...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BIP Bezafibrate Infarction Prevention
CI Cerebral infarction
LI Lacunar infarction
MI Myocardia infarction
MI Postmyocardial infarction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • anterior angular nerve
    ¾Õ ±Ó¹ÙÄû ½Å°æ, ÀüÀ̰³½Å°æ
  • anterior auricular lymph node
    ÀüÀ̰³ ÀÓÆÄÀý
  • anterior auricular nerve
    ÀüÀ̰³ ½Å°æ
  • anterior basal root
    ¾Õ¹Ù´Ú Á¤¸Æ
  • anterior basal segmental bronchus
    ¾Õ¹Ù´Ú ±¸¿ª ±â°üÁö
  • anterior belly of digastric muscle
    µÎ Èû»ì±Ù ¾Õ Èû»ì, ¾ÇÀ̺¹±Ù Àüº¹
  • anterior bony semicircular canal
    Àü ¹Ý±Ô°ü, Àü°ñ ¹Ý±Ô°ü
  • anterior capsular ligament
    Àü¹æ °üÀý³¶ Àδë
  • anterior cerebral artery
    Àü´ë³úµ¿¸Æ
    ³»°æµ¿¸Æ¿¡¼­ ±â¿øÇϸç, ÇÇÁúÁö[¾È¿Í, ÀüµÎ, µÎÁ¤ºÎ], Àü¸Æ¶ô ÃÑÁö ¹× Áß½ÉÁö[³»Ãø¼±Á¶Ã¼µ¿¸ÆÀ» Æ÷ÇÔ], Àü±³±³Å뵿¸ÆÀÇ ºÐÁö¸¦ ³»¸ç, ¾È¿Í, ÀüµÎ¿±, µÎÁ¤¿±ÀÇ ÇÇÁú, ³ö·®, °£³ú, ¼±Á¶Ã¼ ³»Æ÷, Ãø³ú½ÇÀÇ ¸Æ¶ôÃÑ¿¡ ºÐÆ÷ÇÑ´Ù.
  • anterior chamber
    Àü¹æ
    ´« ±¸Á¶ÀÇ ÀϺκÐ. °¢¸·ÀÇ µÚ¿Í ȫäÀÇ ¾Õ¿¡ À§Ä¡ÇÏ´Â °ø°£.
  • anterior chamber angle recession
    Àü¹æ°¢ ÈÄÅð
  • anterior chamber intraocular lens
    Àü¹æ ·»Áî
  • anterior cheek tooth
    ¼Ò±¸Ä¡
  • anterior choroidal artery occlusion syndrome
    Àü¸Æ¶ô Ãѵ¿¸Æ Æó¼â ÁõÈıº
  • anterior circumflex humeral vein
    ¾ÕÀ§ÆÈ ÈÖµ¹ÀÌ Á¤¸Æ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
myocardial depressant factor A low molecular weight peptide of about 800-1000 having a negative inotropic effect. It is released into the circulation during experimental haemorrhagic pancreatitis, severe ischemia, and postoligaemic shock.
(12 Dec 1998)
myocardial diseases Diseases of the myocardium.
(12 Dec 1998)
myocardial infarct imaging <radiology> Tc-99m pyrophosphate (PYP) 20 mCi, peak abnormality 2-3 days, often falsely negative before 2 days, abnormal for 7-10 days, mechanism: calcium influx into ischemic cells, PYP incorporated into crystalline structure, analogous to hydroxyapatite see: nuclear cardiology
(12 Dec 1998)
myocardial insufficiency A condition where there is ineffective pumping of the heart leading to an accumulation of fluid in the lungs. Typical symptoms include shortness of breath with exertion, difficulty breathing when lying flat and leg or ankle swelling. Causes include chronic hypertension, cardiomyopathy and myocardial infarction.
(27 Sep 1997)
myocardial ischemia A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (coronary arteriosclerosis), to obstruction by a thrombus (coronary thrombosis), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (myocardial infarction).
(12 Dec 1998)
myocardial necrosis Irreversible destruction of myocardial (heart muscle) cells.
(27 Sep 1997)
myocardial perfusion imaging <radiology> (thallium scanning) thallium (Tl) 201, acts as potassium analog, dose 2.0 - 3.0 mCi at peak exercise, 4% of injected dose reaches myocardium, imaging: exercise (1-5 min), redistribution (3-4 hrs), views: anterior, LAO 45', left lateral, interpretation: normal, reversible abnormalitymost likely to be exercise-induced ischemia, nonreversible abnormalitymost likely to be prior myocardial infarction, reverse redistribution most likely to be normal areas wash out faster, lung activity most likely to be LV failure during exercise see also: dipyridamole test, nuclear cardiology
(12 Dec 1998)
myocardial reperfusion Generally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing myocardial reperfusion injury.
(12 Dec 1998)
myocardial reperfusion injury Functional, metabolic, or structural changes in ischemic heart muscle thought to result from reperfusion to the ischemic areas. Changes can be fatal to muscle cells and may include oedema with explosive cell swelling and disintegration, sarcolemma disruption, fragmentation of mitochondria, contraction band necrosis, enzyme washout, and calcium overload. Other damage may include haemorrhage and ventricular arrhythmias. One possible mechanism of damage is thought to be oxygen free radicals. Treatment currently includes the introduction of scavengers of oxygen free radicals, and injury is thought to be prevented by warm blood cardioplegic infusion prior to reperfusion.
(12 Dec 1998)
myocardial revascularization The restoration of blood supply to the myocardium.
(12 Dec 1998)
myocardial rigor mortis Irreversible contraction of the left ventricle of the heart as a complication seen in the early period of cardiopulmonary bypass and now avoided by appropriate cardioplegic solutions.
Synonym: myocardial rigor mortis, stone heart.
(05 Mar 2000)
myocardial stunning Prolonged dysfunction of the myocardium after a brief episode of severe ischemia, with gradual return of contractile activity. It occurs frequently, both in the experimental laboratory and in clinical medicine. Since stunned myocardium occurs adjacent to necrotic tissue after prolonged coronary occlusion, many myocardial infarcts may be a mixture of necrotic and stunned tissue.
(12 Dec 1998)
ischemic preconditioning, myocardial Exposure of myocardial tissue to brief, repeated periods of vascular occlusion in order to render the myocardium resistant to the deleterious effects of ischemia or reperfusion. The period of pre-exposure and the number of times the tissue is exposed to ischemia and reperfusion vary, the average being 3 to 5 minutes.
(12 Dec 1998)
anterior part of anterior commissure of brain The anterior part of the anterior or rostral commissure of the brain.
Synonym: pars anterior commissurae rostralis, pars anterior commissurae anterioris cerebri.
(05 Mar 2000)
acute anterior poliomyelitis Inflammation of the anterior cornua of the spinal cord; an acute infectious disease caused by the poliomyelitis virus and marked by fever, pains, and gastroenteric disturbances, followed by a flaccid paralysis of one or more muscular groups, and later by atrophy.
Synonym: acute atrophic paralysis, myogenic paralysis.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á